38 results
Thumbnail

D1.02 - Prevalence of allergic respiratory disorders in urban V/s rural Indian population

Thumbnail

D1.03 - Sustainable and gluten free bread: Are legumes a hidden risk for occupational IgE-mediated respiratory allergy?

Thumbnail

D1.04 - Diagnostic approach for respiratory symptoms linked to microbial contamination in metalworking fluids

Thumbnail

D1.05 - Bet v 6 as a Marker of Pollen Cross-Reactivity in Southern Europe: Insights from a Birch-Free Region

Thumbnail

D1.07 - Profile of sensitization to inhalant allergens in Valencia: Analysis of 1.898 skin prick tests over one year

Thumbnail

D1.09 - Dynamics of pollen allergy in Ukraine during the full-scale invasion shows demand for diagnostics increased with changed sensitization patterns seen

Thumbnail

D1.10 - Tree pollen allergy profile in Ukraine assessed by large-scale molecular component analysis

Thumbnail

D1.11 - Age and Gender Patterns in Fungal Allergen Sensitization: A Study from Central Ukraine

Thumbnail

D1.13 - EHealth tools suitability and technologic innovation use in an Environmental Exposure Chamber

Thumbnail

D1.14 - Molecular Allergy Profiling of Pollen Sensitization in Cluj-Napoca

Thumbnail

D1.15 - Relationship between sensitization to peanuts and tree nuts in children with allergic diseases in a population of the Russian Federation

Thumbnail

D1.12 - Optimal Conventional Diagnostic Approach for Wheat Allergy in Chinese Children

Thumbnail

- D3.100 - Risk Factors and Biomarkers for COVID-19 and Allergic Diseases

Thumbnail

- D3.102 - PROMs Improvement Effects of Biologics in Chronic Rhinosinusitis with Nasal Polyps Patients: Real-life Experience

Thumbnail

- D3.103 - Impact of aspirin-induced bronchospasm on the in vitro Aspirin Hypersensitivity Diagnostic Index in the patients with Aspirin Exacerbated Respiratory Disease

Thumbnail

- D3.104 - A step towards standardized Clinical Remission Criteria for Chronic Rhinosinusitis with Nasal Polyps (CRSwNP): insights from a real-life study

Thumbnail

- D3.105 - Suspected EGPA in a patient on Dupilumab treatment: confirmed diagnosis of sarcoidosis - case report

Thumbnail

- D3.106 - Real-World Dupilumab Effectiveness Through 18 Months in Patients with CRSwNP and Coexisting Asthma: Results from the Global AROMA Registry

Thumbnail

- D3.108 - PTGDR2 Blood Expression as a Potential Biomarker for Predicting Super-Response to IL-5-Targeted Therapies in Severe Asthma

Thumbnail

D3.109 - Lichen planus following dupilumab treatment in patients with severe asthma and nasal sinus polyposis